ANKRD11 and neoplasm: We show that nuclear ANCO1 is a more robust predictor of patient outcomes than cytoplasmic ANCO1, suggesting that at least part of ANCO1′s role as a tumor suppressor relies on its interaction with transcriptional regulatory complexes in the nucleus.